title: Does body height reduction influence interpretation of lung function in COPD patients?
abstract: Vertebral deformities are prevalent in chronic obstructive pulmonary disease (COPD) patients and may cause excessive loss of height. As height is used for calculating reference values for pulmonary function tests, larger than normal height reduction could cause overestimation of lung function. In this cross-sectional study of 465 COPD patients and 462 controls, we explored how often lung function is misinterpreted due to height reduction in COPD patients, and whether the number or severity of vertebral deformities correlate with height reduction. Measured height was compared to recalled tallest height (RTH) and height calculated from arm span (ASH) to assess height reduction. Vertebral deformities were assessed from radiographs and pulmonary function was assessed using standard formulae. Height reduction was frequent in both the study and control groups, and increased with the number and severity of vertebral deformities. When using current measured height, lung function was overestimated in a significant proportion of COPD patients at relatively modest height reductions. The effects were smallest for forced expiratory volume in 1 s and forced vital capacity, and most pronounced for total lung capacity and residual volume. Therefore, we propose that in COPD patients with excessive height reduction, one might use RTH or ASH in calculating predicted values. Furthermore, such patients should be evaluated for co-existing vertebral deformities and osteoporosis.
authors.affiliation: Glittreklinikken, Pb 104 Aaneby, N-1485 Hakadal, Norway. aina.kjensli@glittreklinikken.no
authors.forename: A
authors.initials: A
authors.lastname: Kjensli
authors.forename: M
authors.initials: M
authors.lastname: Ryg
authors.forename: J A
authors.initials: JA
authors.lastname: Falch
authors.forename: G
authors.initials: G
authors.lastname: Armbrecht
authors.forename: L M
authors.initials: LM
authors.lastname: Diep
authors.forename: E F
authors.initials: EF
authors.lastname: Eriksen
authors.forename: I
authors.initials: I
authors.lastname: Ellingsen
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001827:Body Height; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008168:Lung / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009664:Norway; D010024:Osteoporosis / Q000150:complications*; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000473:pathology / Q000628:therapy*; D012016:Reference Values; D012129:Respiratory Function Tests; D012143:Respiratory Physiological Phenomena